- Home
- NTIC vs KYTX Comparison
NTIC vs KYTX Comparison
Compare NTIC & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- KYTX
- Stock Information
- Founded
- NTIC 1970
- KYTX 2018
- Country
- NTIC United States
- KYTX United States
- Employees
- NTIC N/A
- KYTX N/A
- Industry
- NTIC Industrial Specialties
- KYTX
- Sector
- NTIC Industrials
- KYTX
- Exchange
- NTIC Nasdaq
- KYTX NYSE
- Market Cap
- NTIC 105.9M
- KYTX 92.1M
- IPO Year
- NTIC N/A
- KYTX 2024
- Fundamental
- Price
- NTIC $7.30
- KYTX $2.13
- Analyst Decision
- NTIC Buy
- KYTX Buy
- Analyst Count
- NTIC 1
- KYTX 5
- Target Price
- NTIC $20.00
- KYTX $18.80
- AVG Volume (30 Days)
- NTIC 45.0K
- KYTX 205.4K
- Earning Date
- NTIC 04-10-2025
- KYTX 05-16-2025
- Dividend Yield
- NTIC 2.99%
- KYTX N/A
- EPS Growth
- NTIC N/A
- KYTX N/A
- EPS
- NTIC 0.38
- KYTX N/A
- Revenue
- NTIC $84,445,763.00
- KYTX N/A
- Revenue This Year
- NTIC $2.05
- KYTX N/A
- Revenue Next Year
- NTIC $4.70
- KYTX N/A
- P/E Ratio
- NTIC $19.26
- KYTX N/A
- Revenue Growth
- NTIC 2.11
- KYTX N/A
- 52 Week Low
- NTIC $6.75
- KYTX $1.78
- 52 Week High
- NTIC $19.63
- KYTX $17.55
- Technical
- Relative Strength Index (RSI)
- NTIC 31.81
- KYTX 49.61
- Support Level
- NTIC $7.33
- KYTX $1.92
- Resistance Level
- NTIC $7.62
- KYTX $2.38
- Average True Range (ATR)
- NTIC 0.21
- KYTX 0.18
- MACD
- NTIC 0.13
- KYTX 0.02
- Stochastic Oscillator
- NTIC 63.22
- KYTX 55.36
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.